Centene vs Molina Healthcare
CNC and MOH side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNC and MOH compare
Centene is the larger company, worth 3.0 times as much as Molina Healthcare ($37.0B against $12.2B).
Centene grew revenue faster over the last twelve months (9.7% versus −0.95% for Molina Healthcare).
Centene keeps more of each dollar of sales as profit, with a net margin of 0.72% compared with −0.11% at Molina Healthcare.
Centene scores higher on the StockData Score (7 against 5 for Molina Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNC | MOH |
|---|---|---|
| Size and price | ||
| Market cap | $37.0B | $12.2B |
| Share price | $74.77 | $233.09 |
| Change, 1 year | 107% | 68.3% |
| Change, 5 years | 1.2% | −20.3% |
| Beta (5Y) | 1.13 | −0.06 |
| Employees | 61K | 19K |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 2 (better) | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 2 (better) | 0 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 25.6× | – |
| P/S | 0.2× (better) | 0.3× |
| P/B | 1.7× (better) | 2.9× |
| EV/EBITDA | 13.0× (better) | 22.1× |
| P/FCF | 9.4× (better) | 51.1× |
| FCF yield | 10.7% (better) | 2.0% |
| Fair value | $68.78 | – |
| Margin of safety | −8.7% | – |
| Growth | ||
| Revenue growth (TTM) | 9.7% (better) | −0.95% |
| Revenue growth, 5Y average | 11.9% | 18.5% (better) |
| Net income growth (TTM) | – | −105% |
| EPS growth (TTM) | – | −106% |
| EPS growth, 5Y average | – | −4.5% |
| Profitability | ||
| Gross margin | 7.9% | 12.6% (better) |
| Operating margin | 0.49% (better) | 0.39% |
| Net margin | 0.72% (better) | −0.11% |
| FCF margin | 1.9% (better) | 0.54% |
| Return on equity | 6.8% (better) | −1.2% |
| Return on invested capital | 4.6% | – |
| Financial health | ||
| Debt / equity | 0.70 (better) | 0.91 |
| Net debt / EBITDA | −3.60 | −14.44 |
| Interest coverage | 1.6× (better) | 0.8× |
| Current ratio | 1.16 | 1.69 (better) |
| Altman Z-score | 3.30 | 4.22 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | 0.07% (better) | 0.00% |
| Shareholder yield | 0.07% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 98.6% | 108% |
| Held by insiders | 0.79% | 2.1% |
| Insider net buying, 12 months | −$14.6M | −$5.5M (better) |
| Superinvestors holding | 3 (better) | 2 |
| Short interest, % of float | 2.1% | 5.7% |
Go deeper
- CNC stock overview
- CNC income statement
- CNC valuation and score
- MOH stock overview
- MOH income statement
- MOH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.